Lower extremity artery disease in patients with type 2 diabetes

被引:30
作者
Buso, Giacomo [1 ]
Aboyans, Victor [2 ,3 ]
Mazzolai, Lucia [1 ]
机构
[1] CHU Vaudois, Dept Angiol, Ch Mt Paisible 18, CH-1011 Lausanne, Switzerland
[2] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France
[3] Inserm 1098, Sch Med, Paris, France
关键词
Lower extremity artery disease; diabetes; cardiovascular prevention; MAGNETIC-RESONANCE ANGIOGRAPHY; ENDOTHELIAL PROGENITOR CELLS; ANKLE-BRACHIAL INDEX; CARDIOVASCULAR OUTCOMES; RISK-FACTORS; VASCULAR-DISEASE; STATIN THERAPY; FOLLOW-UP; METAANALYSIS; PREVALENCE;
D O I
10.1177/2047487319880044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among all peripheral arterial diseases, lower extremity arterial disease is a serious condition in subjects with type 2 diabetes mellitus, associated with important disability, cardiovascular risk, and socio-economic burden. Patients with both conditions generally display poorer prognosis of affected limbs compared with non-diabetic subjects, leading to increased rates of adverse limb events including amputations. Nonetheless, awareness on lower extremity arterial disease remains somehow suboptimal in the diabetic population, partly related to an atypical clinical presentation in several cases. A regular and appropriate screening for lower extremity arterial disease in patients suffering from type 2 diabetes mellitus is therefore recommended. Affected subjects should receive optimal medical treatment including careful management of the different cardiovascular risk factors through a healthy lifestyle, a regular and structured physical activity, the administration of lipid-lowering, antidiabetic drugs, and (when indicated) antihypertensive and antithrombotic drugs. This review aims to outline current evidence about lower extremity arterial disease in patients with type 2 diabetes mellitus, in order to elucidate its epidemiology, pathophysiology, screening and diagnosis, and management options.
引用
收藏
页码:114 / 124
页数:11
相关论文
共 58 条
[21]   Epidemiology of Peripheral Artery Disease [J].
Criqui, Michael H. ;
Aboyans, Victor .
CIRCULATION RESEARCH, 2015, 116 (09) :1509-1526
[22]   The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial [J].
Dhatariya, Ketan ;
Bain, Stephen C. ;
Buse, John B. ;
Simpson, Richard ;
Tarnow, Lise ;
Kaltoft, Margit Staum ;
Stellfeld, Michael ;
Tornoe, Karen ;
Pratley, Richard E. .
DIABETES CARE, 2018, 41 (10) :2229-2235
[23]   Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men [J].
Eldin, Essam Eldin Mohamed Nour ;
Almarzouki, Abdullah ;
Assiri, Adel Mohamed ;
Elsheikh, Osman Mohammed ;
Mohamed, Badreldin Elsonni Abdalla ;
Babakr, Abdullatif Taha .
DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
[24]   Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis [J].
Fowkes, F. Gerald R. ;
Rudan, Diana ;
Rudan, Igor ;
Aboyans, Victor ;
Denenberg, Julie O. ;
McDermott, Mary M. ;
Norman, Paul E. ;
Sampson, Uchechukwe K. A. ;
Williams, Linda J. ;
Mensah, George A. ;
Criqui, Michael H. .
LANCET, 2013, 382 (9901) :1329-1340
[25]   Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index A Randomized Controlled Trial [J].
Fowkes, F. Gerald R. ;
Price, Jacqueline F. ;
Stewart, Marlene C. W. ;
Butcher, Isabella ;
Leng, Gillian C. ;
Pell, Alistair C. H. ;
Sandercock, Peter A. G. ;
Fox, Keith A. A. ;
Lowe, Gordon D. O. ;
Murray, Gordon D. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (09) :841-848
[26]   Peripheral artery disease: epidemiology and global perspectives [J].
Fowkes, F. Gerry R. ;
Aboyans, Victor ;
Fowkes, Freya J. I. ;
McDermott, Mary M. ;
Sampson, Uchechukwu K. A. ;
Criqui, Michael H. .
NATURE REVIEWS CARDIOLOGY, 2017, 14 (03) :156-170
[27]   LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes [J].
Fukui, Michiaki ;
Tanaka, Muhei ;
Senmaru, Takafumi ;
Nakanishi, Mamoru ;
Mukai, Jun ;
Ohki, Makoto ;
Asano, Mai ;
Yamazaki, Masahiro ;
Hasegawa, Goji ;
Nakamura, Naoto .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (07) :935-938
[28]   A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].
Gent, M ;
Beaumont, D ;
Blanchard, J ;
Bousser, MG ;
Coffman, J ;
Easton, JD ;
Hampton, JR ;
Harker, LA ;
Janzon, L ;
Kusmierek, JJE ;
Panak, E ;
Roberts, RS ;
Shannon, JS ;
Sicurella, J ;
Tognoni, G ;
Topol, EJ ;
Verstraete, M ;
Warlow, C .
LANCET, 1996, 348 (9038) :1329-1339
[29]   Global estimates of diabetes prevalence for 2013 and projections for 2035 [J].
Guariguata, L. ;
Whiting, D. R. ;
Hambleton, I. ;
Beagley, J. ;
Linnenkamp, U. ;
Shaw, J. E. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) :137-149
[30]   Contrast-enhanced magnetic resonance angiography in diabetic patients with infra-genicular peripheral arterial disease: Systematic review [J].
Healy, D. A. ;
Boyle, E. M. ;
Moloney, M. Clarke ;
Hodnett, P. A. ;
Scanlon, T. ;
Grace, P. A. ;
Walsh, S. R. .
INTERNATIONAL JOURNAL OF SURGERY, 2013, 11 (03) :228-232